Page 6 - பல்கலைக்கழகம் ஆஃப் வாஷிங்டன் மருந்து News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Search jobs 17-Mar-2021 Crohn’s Disease Treatment Market Is Expected to Reach US$ 10 Billion at a 4.3% CAGR By 2025 – Coherent Market Insights SEATTLE, March 17, 2021, (PHARMIWEB) Crohn’s Disease Treatment Market – Insights Crohn’s disease is a chronic inflammatory bowel disease that affects the lining of the digestive tract. Stress, diet, malfunctioning of the immune system, and heredity are some of the factors that cause Crohn’s disease. The disease is confined to the colon of the large intestine and ileum of the small intestine and can lead to life-threatening complications in some cases. Although, the condition can occur at any age, it is likely to develop at a young age. Crohn’s disease may comprise of one or more factors that include, bowel obstruction, fistulas, ulcers, anal fissures, colon cancer, and other health issues. There are no specific and dedicated tests to diagnose the Crohn’s disease and is conf

United statesUnited kingdomSouth africaSouth koreaBoehringer ingelheim gmbAsia pacificEli lillyBristol myers squibbAllergan incUniversity of washington medicineJanssen biotech incNational institute of healthTakeda pharmaceutical companyPfizer incAbbvie incEuropean federation of crohn ulcerative colitis associations